McLaughlin Gerald W. bought ALLR
January 28, 2026 · Form 4 insider transaction
McLaughlin Gerald W. bought 45,000 shares of Allarity Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 99 days after the transaction.
Direction
Acquired (buy-side)
Shares
45,000
Price
$0.00
Total value
N/A
InsiderMcLaughlin Gerald W.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 28, 2026
Filing dateMay 7, 2026
Shares owned after70,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, vested in full on the grant date.